Ingenia Therapeutics Inc. (KOSDAQ:950260)
South Korea · Delayed Price · Currency is KRW 18,470
+540 (3.01%)
At close: Sep 18, 2026
Ingenia Therapeutics Market Cap
Ingenia Therapeutics has a market cap or net worth of 913.24 billion as of September 18, 2026.
Market Cap
913.24B
Enterprise Value
900.85B
Revenue
7.42B
Ranking
n/a
PE Ratio
n/a
Stock Price
18,470.00
ChartMarket Cap Chart
Since August 18, 2026, Ingenia Therapeutics's market cap has increased from 889.51B to 913.24B, an increase of 2.67%. That is a compound annual growth rate of 36.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 913.24B | 3.01% |
| Sep 17, 2026 | 886.54B | 14.28% |
| Sep 16, 2026 | 775.79B | 3.56% |
| Sep 15, 2026 | 749.09B | 6.32% |
| Sep 14, 2026 | 704.59B | -7.77% |
| Sep 11, 2026 | 763.92B | -6.42% |
| Sep 10, 2026 | 816.33B | 3.19% |
| Sep 9, 2026 | 791.11B | -0.87% |
| Sep 8, 2026 | 798.04B | -0.55% |
| Sep 7, 2026 | 802.49B | 4.17% |
| Sep 4, 2026 | 770.35B | -1.52% |
| Sep 3, 2026 | 782.21B | -8.29% |
| Sep 2, 2026 | 852.92B | -10.58% |
| Sep 1, 2026 | 953.79B | 9.35% |
| Aug 31, 2026 | 872.20B | -2.00% |
| Aug 28, 2026 | 890.00B | 3.75% |
| Aug 27, 2026 | 857.86B | 0.06% |
| Aug 26, 2026 | 857.37B | 4.71% |
| Aug 25, 2026 | 818.80B | 9.31% |
| Aug 24, 2026 | 749.09B | -3.93% |
| Aug 21, 2026 | 779.74B | -13.97% |
| Aug 20, 2026 | 906.32B | 30.00% |
| Aug 19, 2026 | 697.17B | -21.62% |
| Aug 18, 2026 | 889.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 354.87B |
| DreamCIS | 76.26B |
| P&K Skin Research Center | 51.03B |
| HLB bioStep | 42.75B |
| Kolmar BioTech | 35.68B |
| SLS BIO | 26.89B |
| C&R Research | 24.94B |
| DT&CRO CO. | 21.73B |